Ocumension Therapeutics (1477.HK)

HKD 5.55

(0.36%)

Gross Profit Summary of Ocumension Therapeutics

Ocumension Therapeutics's latest annual gross profit in 2023 was 144.36 Million CNY , up 40.27% from previous year.
Ocumension Therapeutics's latest quarterly gross profit in 2023 FY was 144.36 Million CNY , up 40.27% from previous quarter.
Ocumension Therapeutics reported a annual gross profit of 102.91 Million CNY in annual gross profit 2022, up 178.64% from previous year.
Ocumension Therapeutics reported a annual gross profit of 36.93 Million CNY in annual gross profit 2021, up 224.79% from previous year.
Ocumension Therapeutics reported a quarterly gross profit of 40.82 Million CNY for 2023 Q4, down 0.0% from previous quarter.
Ocumension Therapeutics reported a quarterly gross profit of 144.36 Million CNY for 2023 FY, up 40.27% from previous quarter.

Annual Gross Profit Chart of Ocumension Therapeutics (2023 - 2018)

Historical Annual Gross Profit of Ocumension Therapeutics (2023 - 2018)

Year	Gross Profit	Gross Profit Growth
2023	144.36 Million CNY	40.27%
2022	102.91 Million CNY	178.64%
2021	36.93 Million CNY	224.79%
2020	11.37 Million CNY	6217.78%
2019	180 Thousand CNY	0.0%
2018	- CNY	0.0%

Year	Gross Profit	Gross Profit Growth
2023 Q2	31.35 Million CNY	0.0%
2023 Q4	40.82 Million CNY	0.0%
2023 FY	144.36 Million CNY	40.27%
2023 Q1	31.35 Million CNY	-8.6%
2023 Q3	40.82 Million CNY	30.21%
2022 Q1	17.15 Million CNY	61.45%
2022 Q2	17.15 Million CNY	0.0%
2022 Q4	34.3 Million CNY	0.0%
2022 Q3	34.3 Million CNY	100.01%
2022 FY	102.91 Million CNY	178.64%
2021 Q1	7.84 Million CNY	66.14%
2021 FY	36.93 Million CNY	224.79%
2021 Q4	10.62 Million CNY	0.0%
2021 Q3	10.62 Million CNY	35.45%
2021 Q2	7.84 Million CNY	0.0%
2020 Q3	4.72 Million CNY	389.22%
2020 Q2	965 Thousand CNY	0.0%
2020 FY	11.37 Million CNY	6217.78%
2020 Q1	965 Thousand CNY	972.22%
2020 Q4	4.72 Million CNY	0.0%
2019 Q3	90 Thousand CNY	0.0%
2019 FY	180 Thousand CNY	0.0%
2019 Q4	90 Thousand CNY	0.0%
2019 Q1	- CNY	0.0%
2019 Q2	- CNY	0.0%
2018 FY	- CNY	0.0%

Peer Gross Profit Comparison of Ocumension Therapeutics

Name	Gross Profit	Gross Profit Difference
Uni-Bio Science Group Limited	392.81 Million HKD	63.249%
CK Life Sciences Int'l., (Holdings) Inc.	947.7 Million HKD	84.767%